Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
EQS Group
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Financials: Waiting for the whistleblowing tailwind === Management guidance is for FY22e revenue growth of 30β40% (was 30β50%) and EBITDA of β¬6.0β10.0m (unchanged). Edison Investment Research's forecasts are also unchanged following the Q122 results, albeit its revenue number now lies towards the top of the indicated range. The Q122 figures showed revenues up 34% to β¬14.1m, with benefit from the acquisition of Business Keeper (consolidated from July 2021) lifting that figure from 7%. Managementβs ambition is to build to group revenues of β¬130m for FY25e, driven mostly by demand for compliance products and services as the suite offered through the COCKPIT platform builds and cross-selling becomes more prevalent. Whistleblowing is set to be the main stimulus for this growth as the EU regulation becomes law across Europe. EBITDA margin is being held down currently (10.7% in FY22e) by the investment to grasp the whistleblowing opportunity and grow the client roster. The medium-term plan envisages its recovery to over 30% by FY25e, which Edison Investment Research regards as a challenging but feasible ambition. The Q122 fund-raise has put the balance sheet in a healthier position post the acquisitions, with gearing of under 10%. Given the high proportion of SaaS revenues, EQS should fundamentally have healthy operational cash conversion of around 100%, with the larger capital spend on building the cloud-based platform completed over FY17β20.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)